Contemporary imaging in sarcoma Journal Article


Authors: Landa, J.; Schwartz, L. H.
Article Title: Contemporary imaging in sarcoma
Abstract: Sarcomas are a heterogeneous group of &gt;50 subtypes of neoplasm. It is imperative to obtain appropriate imaging of these tumors in order to adequately assess, characterize, and stage bone and soft tissue sarcomas. Anatomic imaging such as radiographs, computed tomography, and magnetic resonance imaging (MRI) remain the foundation for both biopsy planning and postoperative evaluation of these neoplasms. However, anatomic imaging may not be entirely accurate in the evaluation of treatment response. Newer techniques, such <sup>18</sup>F- fluorodeoxyglucose positron emission tomography, are being used to evaluate distant metastases. Newer radiopharmaceuticals, such as <sup>18</sup>F- fluorodeoxythymidine, are being developed to assist in the differentiation between benign and low-grade malignant neoplasms. Newer functional imaging techniques, such as dynamic contrast-enhanced MRI and diffusionweighted imaging, among others, are being developed to evaluate treatment response. ©AlphaMed Press.
Keywords: osteosarcoma; adolescent; adult; treatment outcome; aged; bone neoplasms; bone tumor; young adult; unclassified drug; review; cancer staging; nuclear magnetic resonance imaging; positron emission tomography; magnetic resonance imaging; neoplasm staging; radiopharmaceuticals; metastasis; computer assisted tomography; differential diagnosis; tomography, x-ray computed; tumor biopsy; pathology; diagnostic imaging; sarcoma; diagnostic agent; fluorodeoxyglucose f 18; fluorodeoxyglucose f18; positron-emission tomography; neoplasm metastasis; radiopharmaceutical agent; scintiscanning; soft tissue sarcoma; malignant neoplastic disease; radiography; benign tumor; fluorine 18; soft tissue neoplasms; soft tissue tumor; functional imaging; positron emission tomography (pet); fluorodeoxythymidine f 18; thymidine
Journal Title: The Oncologist
Volume: 14
Issue: 10
ISSN: 1083-7159
Publisher: Oxford University Press  
Date Published: 2009-10-01
Start Page: 1021
End Page: 1038
Language: English
DOI: 10.1634/theoncologist.2009-0194
PUBMED: 19789392
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 1" - "Export Date: 30 November 2010" - "CODEN: OCOLF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lawrence H Schwartz
    306 Schwartz
  2. Jonathan Landa
    37 Landa